AstraZeneca plans to increase investment and scope of its Virginia manufacturing facility to $4.5 billion, creating 3,600 new jobs

Core Insights - AstraZeneca will invest $4.5 billion in a new manufacturing facility in Virginia, increasing its investment by $500 million to enhance manufacturing capabilities for a broader range of medicines, including cancer treatments [1] - This investment is part of a larger historic $50 billion investment announced in July 2025 [1] - The new facility will be located at Rivanna Futures in Albemarle County and is expected to create approximately 3,600 direct and indirect jobs [1]